2 followers
SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant fungal infections.
David Angulo
Immunome
2 followers
Day One Biopharmaceuticals
1 follower
Apogee Therapeutics
1 follower
PrognomiQ
1 follower
Thermo Fisher Scientific
165 followers
Gilead Sciences
128 followers
Regeneron
93 followers
Neuralink
60 followers
Alexion Pharmaceuticals
34 followers
GRAIL
27 followers
Bio-Rad Laboratories
20 followers
Explore companies